VIable

NDHI
NAT IONAL DIALOGUE FOR
Healthcare Innovation
Medication Therapy
Management
Organization Overview
• McKesson is the oldest and largest healthcare
company in the nation, serving more than 50% of
U.S. hospitals, 20% of physicians, and 96% of the
top 25 health plans
• The company collaborates with healthcare organizations
of all types to strengthen the health of their
businesses by helping them control costs, develop
efficiencies, and improve quality
• The company delivers one-third of all medications
used daily in North America
Background
In 2012, the Congressional Budget Office estimated
that a 1% increase in the number of prescriptions filled
by beneficiaries would cause Medicare’s spending on
medical services to drop 0.2%. Between $100 and $300
billion of avoidable healthcare costs have been attributed
to non-adherence in the US annually, representing 3%
to 10% of total US healthcare costs. In response to the
government’s focus on decreasing healthcare spend,
healthcare plans and other key stakeholders are now
incentivized to improve the quality metrics associated
with their beneficiaries.
The pharmacist can have a direct impact on patient
health and associated costs by improving adherence
and closing gaps in care. This has led to the development
of Medication Therapy Management (MTM)
services, through which patients are counseled about
appropriate medication use, potential drug interactions,
adherence strategies, and other topics. After many
failed attempts to deliver MTM services centrally, a
majority of plans have relied on community pharmacies
to impact these metrics. The McKesson MTM program
is designed to leverage the strength of the independent
pharmacy-patient relationship to increase both the level
and quality of patient engagement in MTM services.
Program Details
The goal of McKesson’s MTM program is to support
pharmacies in their evolution to a patient-centric business
model, focused on driving outcomes and expanding
clinical services offerings to meet the broader industry
needs. Areas of focus include adherence for diabetes,
hyperlipidemia and hypertension, high risk medications,
and diabetes gaps in care.
In the fall of 2013, the program partnered with a major
PBM and was piloted in 3 states in the Northwest. Based
on its success, a nationwide program was launched
in 2014. The roll-out included:
• Mass enrollment of approximately 6,000 pharmacies
in the MTM vendor program and participation from
all major PBMs
• A series of over 100 live “Town Hall” educational
sessions for independent pharmacies each year,
for the last three years, which are focused on
the changing healthcare landscape, importance
of clinical performance, and necessary actions
for improvement
An Initiative of the
23 |
Medication Therapy Management